D. Beasley

发表

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

C. Schein, Gregory D. Gromowski, A. Barrett, 2010, Virology.

Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype.

A. Barrett, D. Beasley, C. Davis, 2005, Virology.

Virulence of West Nile Virus in Different Animal Hosts

A. Barrett, D. Beasley, 2009 .

Supramolecular peptide hydrogel adjuvanted subunit vaccine elicits protective antibody responses against West Nile virus.

D. Beasley, B. Friedrich, J. Rudra, 2016, Vaccine.

Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model

D. Beasley, W. Baze, J. Peterson, 2020, Pathogens.

Recent advances in the molecular biology of west nile virus.

D. Beasley, 2005, Current molecular medicine.

Experimental infection of rhesus macaques with West Nile virus: level and duration of viremia and kinetics of the antibody response after infection.

A. Barrett, D. Beasley, R. Tesh, 2004, The Journal of infectious diseases.

In Vivo Activity of Repurposed Amodiaquine as a Host-Targeting Therapy for the Treatment of Anthrax

C. Kao, D. Beasley, C. Klimko, 2021, ACS infectious diseases.

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development

A. Barrett, D. Beasley, Nathen E. Bopp, 2020, NPJ vaccines.

Current status of Severe Fever with Thrombocytopenia Syndrome vaccine development.

A. Barrett, D. Beasley, L. Reece, 2018, Current opinion in virology.

Defining a correlate of protection for chikungunya virus vaccines.

D. Beasley, B. Schnierle, G. Milligan, 2019, Vaccine.

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

S. Hallam, A. Barrett, D. Beasley, 2018, npj Vaccines.

Zika virus infection elicits auto-antibodies to C1q

S. Hallam, D. Beasley, P. Shi, 2018, Scientific Reports.

Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes.

D. Beasley, T. Monath, D. Trent, 2013, Virus research.

Multiplexed Digital mRNA Profiling of the Inflammatory Response in the West Nile Swiss Webster Mouse Model

D. Beasley, A. Carillo, M. LaBute, 2014, PLoS neglected tropical diseases.

Status of research and development of vaccines for chikungunya.

D. Beasley, Jesse H. Erasmus, C. B. Chesson, 2016, Vaccine.

Characterization of a West Nile Virus Isolate from a Human on the Gulf Coast of Texas

A. Barrett, D. Beasley, C. Davis, 2004, Journal of Clinical Microbiology.

Challenges for the utilization of vaccines against arthritogenic alphaviruses

D. Beasley, J. Aaskov, 2016 .

Enhancement of protein expression by alphavirus replicons by designing self-replicating subgenomic RNAs

D. Beasley, E. Frolova, I. Frolov, 2014, Proceedings of the National Academy of Sciences.

Origin and Evolution of Japanese Encephalitis Virus in Southeast Asia

A. Barrett, D. Beasley, T. Solomon, 2003, Journal of Virology.

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype.

A. Barrett, D. Beasley, Li Li, 2002, Virology.

Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done?

A. Barrett, D. Beasley, R. Tesh, 2013, Antiviral research.

Current use and development of vaccines for Japanese encephalitis

D. Beasley, T. Solomon, P. Lewthwaite, 2008, Expert opinion on biological therapy.

Emergence of attenuated West Nile virus variants in Texas, 2003.

A. Barrett, D. Beasley, C. Davis, 2004, Virology.

Genome Sequence and Attenuating Mutations in West Nile Virus Isolate from Mexico

A. Barrett, D. Beasley, C. Davis, 2004, Emerging infectious diseases.

Long Range Communication in the Envelope Protein Domain III and Its Effect on the Resistance of West Nile Virus to Antibody-mediated Neutralization*

A. Barrett, Rodrigo A. Maillard, D. Beasley, 2008, Journal of Biological Chemistry.

Solution structure of the envelope protein domain III of dengue-4 virus.

Gregory D. Gromowski, A. Barrett, D. Volk, 2007, Virology.

Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus.

D. Beasley, S. Higgs, B. S. Schneider, 2004, The American journal of tropical medicine and hygiene.

The Infectious Agent

A. Barrett, D. Beasley, 2008 .

Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections.

A. Barrett, D. Gorenstein, D. Beasley, 2007, The Journal of general virology.

Selection of Thioaptamers for Diagnostics and Therapeutics

A. Barrett, D. Volk, D. Gorenstein, 2006, Annals of the New York Academy of Sciences.

Structure of the envelope protein domain III of Omsk hemorrhagic fever virus.

A. Barrett, D. Volk, D. Gorenstein, 2006, Virology.

Supplementary Table S1

George Davey Smith, A. Barrett, Shuliu Zhang, 2008 .

Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity.

Patrick M. Guertin, D. Beasley, T. Monath, 2010, Vaccine.

Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus.

Shuliu Zhang, E. I. Bovshik, D. Beasley, 2009, The Journal of infectious diseases.

Long-term, West Nile virus-induced neurological changes: A comparison of patients and rodent models

D. Beasley, K. Dineley, D. Bente, 2020, Brain, behavior, & immunity - health.

Molecular evolution of lineage 2 West Nile virus.

A. Barrett, D. Beasley, C. Davis, 2013, The Journal of general virology.

Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States.

A. Barrett, D. Beasley, C. Davis, 2003, Virology.

Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development

S. Hallam, A. Barrett, D. Beasley, 2018, npj Vaccines.

First vaccine approval under the FDA Animal Rule

D. Beasley, T. Brasel, J. Comer, 2016, npj Vaccines.

Envelope and pre-membrane protein structural amino acid mutations mediate diminished avian growth and virulence of a Mexican West Nile virus isolate.

A. Barrett, C. Huang, D. Beasley, 2011, The Journal of general virology.

Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas.

A. Barrett, D. Beasley, A. Brault, 2011, The American journal of tropical medicine and hygiene.

Short report: serological evidence of West Nile virus activity in El Salvador.

D. Beasley, R. Tesh, S. Weaver, 2005, The American journal of tropical medicine and hygiene.

West Nile Virus in Mexico: Evidence of Widespread Circulation since July 2002.

A. Barrett, D. Beasley, R. Tesh, 2003, Emerging infectious diseases.

Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III.

C. Huang, D. Beasley, Jessica A. Plante, 2016, Virology.

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects

D. Beasley, 2011, Expert review of vaccines.

A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice.

A. Barrett, Shuliu Zhang, D. Beasley, 2006, Virology.

Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy.

Dennis A Bente, D. Beasley, Alexander J. McAuley, 2015, Antiviral research.

Development pathway for biodefense vaccines.

A. Barrett, D. Beasley, 2009, Vaccine.

Envelope Protein Glycosylation Status Influences Mouse Neuroinvasion Phenotype of Genetic Lineage 1 West Nile Virus Strains

Gregory D. Gromowski, A. Barrett, Shuliu Zhang, 2005, Journal of Virology.

Genetic variation in the 3' non-coding region of dengue viruses.

A. Barrett, D. Beasley, E. Wang, 2001, Virology.

Characterization of Culex Flavivirus (Flaviviridae) strains isolated from mosquitoes in the United States and Trinidad.

D. Beasley, H. Guzmán, R. Tesh, 2009, Virology.

Research and development of Zika virus vaccines

A. Barrett, D. Beasley, J. Hombach, 2016, npj Vaccines.

Persistent infection with West Nile virus years after initial infection.

Jessica A. Lewis, D. Beasley, R. Tesh, 2010, The Journal of infectious diseases.

Mutational analysis of the West Nile virus NS4B protein.

A. Barrett, C. Huang, D. Beasley, 2012, Virology.

Co-circulation of West Nile Virus Variants, Arizona, USA, 2010

D. Beasley, J. Mutebi, Jessica A. Plante, 2014, Emerging infectious diseases.

Identification of Neutralizing Epitopes within Structural Domain III of the West Nile Virus Envelope Protein

A. Barrett, D. Beasley, 2002, Journal of Virology.

Baseline mapping of Oropouche virology, epidemiology, therapeutics, and vaccine research and development

A. Barrett, D. Beasley, M. Files, 2022, NPJ vaccines.

GeneSV – an Approach to Help Characterize Possible Variations in Genomic and Protein Sequences

Nikos Vasilakis, Scott C. Weaver, Adam Zemla, 2012, Bioinformatics and biology insights.

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes.

Gregory D. Gromowski, A. Barrett, D. Beasley, 2012, Virology.

Introductions of West Nile Virus Strains to Mexico

A. Barrett, D. Beasley, C. Davis, 2006, Emerging infectious diseases.

Genetic Variation among Temporally and Geographically Distinct West Nile Virus Isolates, United States, 2001, 2002

A. Barrett, D. Beasley, C. Davis, 2003, Emerging Infectious Diseases.

Molecular determinants of virulence of West Nile virus in North America.

A. Barrett, D. Beasley, C. Davis, 2004, Archives of virology. Supplementum.

Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus.

A. Barrett, C. Huang, D. Beasley, 2010, Vaccine.

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

D. Beasley, V. von Messling, T. Avšič-Županc, 2017, npj Vaccines.

Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

D. Beasley, 2011, Immunotherapy.

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

D. Beasley, V. von Messling, T. Avšič-Županc, 2017, npj Vaccines.

Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders.

A. Barrett, D. Beasley, R. Tesh, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

West Nile encephalitis

D. Beasley, T. Solomon, M. Ooi, 2003, BMJ : British Medical Journal.

Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strains.

A. Barrett, D. Beasley, Li Li, 2005, Virology.

Solution Structure and Antibody Binding Studies of the Envelope Protein Domain III from the New York Strain of West Nile Virus*

A. Barrett, D. Volk, D. Gorenstein, 2004, Journal of Biological Chemistry.

Nucleotide sequencing and serological evidence that the recently recognized deer tick virus is a genotype of Powassan virus.

A. Barrett, D. Beasley, M. Holbrook, 2001, Virus research.

Inhibition of Phosphodiesterase 12 results in Antiviral Activity against several RNA Viruses including SARS-CoV-2

D. Beasley, G. Screaton, M. Thursz, 2022, bioRxiv.

New international guidance on quality, safety and efficacy of DNA vaccines

D. Beasley, 2020, npj Vaccines.

Vaccines for Biodefense and Emerging and Neglected Diseases

Melissa M. Eitzen, D. Beasley, Andrew G. McNees, 2009 .

NMR assignments of the sylvatic dengue 1 virus envelope protein domain III

A. Barrett, D. Volk, D. Gorenstein, 2008, Biomolecular NMR assignments.

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.

A. Barrett, D. Beasley, Li Li, 2004, Vaccine.

A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus.

A. Barrett, Shuliu Zhang, C. Huang, 2006, Virology.

Preclinical Vaccine Development: Implementing the Food and Drug Administration’s Good Laboratory Practices in a Biocontainment Environment—A University BSL3/BSL4 Laboratory Perspective

Melissa M. Eitzen, D. Beasley, A. G. McNees, 2009 .

Zika virus infection elicits auto-antibodies to C1q

S. Hallam, D. Beasley, P. Shi, 2018, Scientific Reports.

Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence

C. Huang, D. Beasley, Jessica A. Plante, 2016, Journal of Virology.

Jatobal virus is a reassortant containing the small RNA of Oropouche virus.

A. Barrett, D. Beasley, R. Tesh, 2001, Virus research.

Nucleotide sequence and deduced amino acid sequence of the medium RNA segment of Oropouche, a Simbu serogroup virus: comparison with the middle RNA of Bunyamwera and California serogroup viruses.

A. Barrett, D. Beasley, H. Wang, 2001, Virus research.

Use of a Recombinant Envelope Protein Subunit Antigen for Specific Serological Diagnosis of West Nile Virus Infection

A. Barrett, D. Beasley, R. Tesh, 2004, Journal of Clinical Microbiology.

Immunogenicity and Efficacy of Flagellin-Envelope Fusion Dengue Vaccines in Mice and Monkeys

D. Beasley, Langzhou Song, Wenzhe Liu, 2015, Clinical and Vaccine Immunology.

West Nile Virus Strains Differ in Mouse Neurovirulence and Binding to Mouse or Human Brain Membrane Receptor Preparations

A. Barrett, D. Beasley, Li Li, 2001, Annals of the New York Academy of Sciences.

Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates

Gregory D. Gromowski, A. Barrett, D. Beasley, 2023, Nature.

Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies.

D. Beasley, J. Aaskov, D. W. Beasley, 2001, Virology.

Zika virus infection elicits auto-antibodies to C1q

S. Hallam, D. Beasley, P. Shi, 2018, Scientific Reports.

Propagation and Titration of West Nile Virus on Vero Cells.

D. Beasley, Alexander J. McAuley, 2016, Methods in molecular biology.

Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit model

D. Beasley, W. Baze, E. Whorton, 2023, bioRxiv.

Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

D. Beasley, M. Diamond, S. Weaver, 2015, PLoS neglected tropical diseases.

Real-time reverse transcriptase-polymerase chain reaction quantification of West Nile virus transmitted by Culex pipiens quinquefasciatus.

D. Beasley, S. Higgs, B. S. Schneider, 2004, American Journal of Tropical Medicine and Hygiene.

Reduced avian virulence and viremia of West Nile virus isolates from Mexico and Texas.

A. Barrett, D. Beasley, A. Brault, 2011, The American journal of tropical medicine and hygiene.

Genetic variation of St. Louis encephalitis virus

Shuliu Zhang, D. Beasley, H. Guzmán, 2008, The Journal of general virology.

Development of Vaccines for Microbial Diseases

D. Beasley, D. Trent, 2014 .

Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects

D. Beasley, 2011, Expert review of vaccines.

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes.

Gregory D. Gromowski, A. Barrett, D. Beasley, 2012, Virology.

Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system.

D. Beasley, D. Fitzpatrick, H. Bielefeldt-Ohmann, 1997, The Journal of general virology.

Vaccine value profile for Chikungunya

D. Beasley, S. Sahastrabuddhe, R. Hutubessy, 2023, Vaccine.